drugset / Trial / NCT05891886
Supplemental Oxygen in Pulmonary Embolism (SO-PE)
Phase 0
Recruiting
80 enrolled
Massachusetts General Hospital
Aarhus University Hospital · collabNational Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedCrossoverSingle-blindOther
Summary
A study of how supplemental oxygen helps patients with acute pulmonary embolism (PE). Hypothesis: Oxygen affects right ventricular dysfunction (RVD) in patients with acute pulmonary embolism (PE) primarily by relieving hypoxic pulmonary vasoconstriction and reducing pulmonary pressure (PA) pressure, and that this process is metabolically driven.
Timeline
- Start
- 2023-10-01
- Primary completion
- 2027-06-30
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxygen | Other / unclassified | 60 % | Inhaled |